Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China

Keyphrases

• Androgen Receptor Gene 100%
• Prostate Cancer Risk 100%
• Repeat Length 100%
• Population-based Case-control Study 100%
• Study in China 100%
• GGN Repeat 100%
• CAG Repeat Length 100%
• CAG Repeat 100%
• Prostate Cancer 50%
• Androgen Receptor 37%
• Clinically Significant Prostate Cancer 37%
• Polymorphism 37%
• High Risk 25%
• Confidence Interval 25%
• Polyglutamine 25%
• Polyglycine 25%
• Low-risk Population 25%
• Prostate Cancer Patients 12%
• Receptor Function 12%
• Population-based Study 12%
• Genomic DNA (gDNA) 12%
• Racial Differences 12%
• Odds Ratio 12%
• Healthy Controls 12%
• Transactivation 12%
• Chinese Men 12%
• Ethnic Variation 12%
• Direct Sequencing 12%
• Very Low Risk 12%
• CAG Trinucleotide Repeat 12%
• Androgenic Activity 12%

Biochemistry, Genetics and Molecular Biology

• Case-Control Study 100%
• Receptor Gene 100%
• CAG Repeat 100%
• Androgen Receptor 100%
• Low Risk Population 25%
• Trinucleotide Repeat Expansion 12%
• Transactivation 12%
• Race Difference 12%
• Genomics 12%

Neuroscience

• Receptor Gene 100%
• CAG Repeat 100%
• Androgen Receptor 100%
• Prostate 50%
• Polyglutamine 25%
• Genomic DNA 12%
• Trinucleotide Repeat 12%
• Transactivation 12%